Activation of peroxisome-proliferator-activated receptors α and γ mediates remote ischemic preconditioning against myocardial infarction in vivo

被引:29
|
作者
Lotz, Christopher [1 ]
Lazariotto, Maria [2 ]
Redel, Andreas
Smul, Thorsten M.
Stumpner, Jan
Blomeyer, Christoph
Tischer-Zeitz, Tobias
Schmidt, Johannes
Pociej, Joanna
Roewer, Norbert
Kehl, Franz [3 ]
Lange, Markus
机构
[1] Univ Wurzburg, Klin & Poliklin Anasthesiol, Zentrum Operat Med, Dept Anesthesiol, D-97080 Wurzburg, Germany
[2] Univ Wurzburg, Dept Cardiac Thorac & Thorac Vasc Surg, D-97080 Wurzburg, Germany
[3] Staedt Klinikum Karlsruhe, Dept Anesthesiol, Karlsruhe, Germany
关键词
myocardial ischemia/reperfusion-injury; nitric oxide; cardioprotection; NITRIC-OXIDE SYNTHASE; FACTOR-KAPPA-B; PPAR-ALPHA; REPERFUSION INJURY; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); UP-REGULATION; RABBIT HEART; RAT-HEART; PROTECTION; LIGANDS;
D O I
10.1258/ebm.2010.010210
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Remote ischemic preconditioning (remote IPC) elicits a protective cardiac phenotype against myocardial ischemic injury. The remote stimulus has been hypothesized to act on major signaling pathways; however, its molecular targets remain largely undefined. We hypothesized that remote IPC exerts its effects by activating the peroxisome-proliferator-activated receptors (PPARs) alpha and gamma, which have been previously implicated in cardioprotective signaling. Male New Zealand white rabbits (n = 78) were subjected to a 30-min coronary artery occlusion followed by three hours of reperlusion. Three cycles of remote IPC consisting of 10-min renal ischemia/reperfusion were performed. The animals either received the PPAR alpha-antagonist GW6471 or the PPAR gamma-antagonist GW9662 alone or combined with remote IPC. Infarct size was determined gravimetrically. Tissue levels of 15d-prostaglandin J(2) (15d-PGJ(2)), as well as the PPAR DNA binding were measured using specific assays. Reverse transcriptase polymerase chain reaction was used to analyze changes in endothelial nitric oxide synthase or inducible nitric oxide synthase (iNOS) mRNA expression in relative quantity (RQ). Data are mean +/- SD. As a result, remote IPC significantly reduced the myocardial infarct size (42.2 +/- 4.9%* versus 61 +/- 1.9%), accompanied by an increased PPAR DNA-binding (189.6 +/- 19.8RLU* versus 44.4 +/- 9RLU), increased iNOS expression (3.5 +/- 1RQ* versus 1RQ), as well as 15d-PGJ(2) levels (179.7 +/- 7.9 pg/mL* versus 127.9 +/- 7.6 pg/mL). The protective response elicited by remote IPC, as well as the accompanying molecular changes were abolished by inhibiting PPAR alpha (56.8 +/- 4.7%; 61.1 +/- 14.2RLU; and 1.91 +/- 0.96RQ, respectively) or PPAR gamma (57.4 +/- 3.3%; 52.7 +/- 16.9RLU; and 1.54 +/- 0.25RQ, respectively). (*Significantly different from control P < 0.05). In conclusion, the obtained results indicate that both PPAR alpha and PPAR gamma play an essential role in remote IPC against myocardial infarction, impinging on the transcriptional control of iNOS expression.
引用
收藏
页码:113 / 122
页数:10
相关论文
共 50 条
  • [31] Peroxisome-proliferator-activated receptors and the control of levels of prostaglandin-endoperoxide synthase 2 by arachidonic acid in the bovine uterus
    Sheldrick, E. Linda R.
    Derecka, Kamila
    Marshall, Elaine
    Chin, Evonne C.
    Hodges, Louise
    Wathes, D. Claire
    Abayasekara, D. Robert E.
    Flint, Anthony P. F.
    BIOCHEMICAL JOURNAL, 2007, 406 : 175 - 183
  • [32] Fibrates reduce plasminogen activator inhibitor type-1 in adipose cells via peroxisome-proliferator-activated receptors α
    Ernst, Sandra
    Leugers, Anne
    Sobel, Burton E.
    Bode, Christoph
    Nordt, Thomas K.
    Zirlik, Andreas
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E58 - E58
  • [33] Interaction of δ and κ opioid receptors with adenosine A1 receptors mediates cardioprotection by remote ischemic preconditioning
    Surendra, Harinee
    Diaz, Roberto J.
    Harvey, Kordan
    Tropak, Michael
    Callahan, John
    Hinek, Alina
    Hossain, Taneya
    Redington, Andrew
    Wilson, Gregory J.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2013, 60 : 142 - 150
  • [34] Peroxisome-proliferator-activated receptor δ mediates the effects of long-chain fatty acids on post-confluent cell proliferation
    Jehl-Pietri, C
    Bastie, C
    Gillot, I
    Luquet, S
    Grimaldi, PA
    BIOCHEMICAL JOURNAL, 2000, 350 : 93 - 98
  • [35] Apoptotic mimicry:: phosphatidylserine liposomes reduce inflammation through activation of peroxisome proliferator-activated receptors (PPARs) in vivo
    Ramos, G. C.
    Fernandes, D.
    Charao, C. T.
    Souza, D. G.
    Teixeira, M. M.
    Assreuy, J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 151 (06) : 844 - 850
  • [36] Peroxisome proliferator-activated receptors (PPAR) downregulate the expression of pro-inflammatory molecules in an experimental model of myocardial infarction
    de la Luz Ibarra-Lara, Maria
    Sanchez-Aguilar, Maria
    Soria, Elizabeth
    Carlos Torres-Narvaez, Juan
    Del Valle-Mondragon, Leonardo
    Graciela Cervantes-Perez, Luz
    Perez-Severiano, Francisca
    del Carmen Ramirez-Ortega, Margarita
    Pastelin-Hernandez, Gustavo
    Hugo Oidor-Chan, Victor
    Sanchez-Mendoza, Alicia
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2016, 94 (06) : 634 - 642
  • [37] Treprostinil Mediated Activation of Peroxisome Proliferator-Activated Receptors in Pulmonary Hypertension.
    Lai, Y. -J.
    Pullamsetti, S. S.
    Weissmann, N.
    Ghofrani, H. A.
    Voswinckel, R.
    Seeger, W.
    Grimminger, F.
    Schermuly, R. T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [38] Negative regulation of the basophil activation by natural ligands for peroxisome proliferator-activated receptors
    Fujimura, Y
    Tachibana, H
    Yamada, K
    ANIMAL CELL TECHNOLOGY: BASIC & APPLIED ASPECTS, VOL 13, 2003, : 369 - 374
  • [39] Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters
    Bility, MT
    Thompson, JT
    McKee, RH
    David, RM
    Butala, JH
    Vanden Heuvel, JP
    Peters, JM
    TOXICOLOGICAL SCIENCES, 2004, 82 (01) : 170 - 182
  • [40] Cannabinoid activation of peroxisome proliferator-activated receptors: Potential for modulation of inflammatory disease
    O'Sullivan, S. E.
    Kendall, D. A.
    IMMUNOBIOLOGY, 2010, 215 (08) : 611 - 616